Serum Neuron-Specific Enolase as a Biomarker of Neonatal Brain Injury-New Perspectives for the Identification of Preterm Neonates at High Risk for Severe Intraventricular Hemorrhage

Neonatal brain injury (NBI) is a critical condition for preterm neonates with potential long-term adverse neurodevelopmental outcomes. This prospective longitudinal case-control study aimed at investigating the levels and prognostic value of serum neuron-specific enolase (NSE) during the first 3 day...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomolecules (Basel, Switzerland) Switzerland), 2024-04, Vol.14 (4), p.434
Hauptverfasser: Metallinou, Dimitra, Karampas, Grigorios, Pavlou, Maria-Loukia, Louma, Maria-Ioanna, Mantzou, Aimilia, Sarantaki, Antigoni, Nanou, Christina, Gourounti, Kleanthi, Tzeli, Maria, Pantelaki, Nikoletta, Tzamakos, Evangelos, Boutsikou, Theodora, Lykeridou, Aikaterini, Iacovidou, Nicoletta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Neonatal brain injury (NBI) is a critical condition for preterm neonates with potential long-term adverse neurodevelopmental outcomes. This prospective longitudinal case-control study aimed at investigating the levels and prognostic value of serum neuron-specific enolase (NSE) during the first 3 days of life in preterm neonates (
ISSN:2218-273X
2218-273X
DOI:10.3390/biom14040434